Study cohort began collecting data on newborns through adulthood, and may offer objective clues on asthma and COPD disease ...

Innoviva's shift to specialty therapeutics is backed by strong financials and a robust pipeline. Read why INVA stock presents ...

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...

Amid stock market reeling, these five shares have surged up to 33 per cent in last one month - Godfrey Phillips, Godrej ...

It forecasts that the repurchases - which are due to complete in 18 months - will boost core earnings by 6% to 8% in 2025 ...

With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be acquired next.

The company's consolidated net profit jumped multifold to Rs 230 crore as compared to Rs 46 crore a year ago in the December ...

A new national survey of Canadian adults reveals significant gaps in understanding of shingles risk factors and a lack of ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90.

CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...

If your portfolio is concentrated in US tech stocks, then a taste of Europe may be what you need.